RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • SGLT2 inhibitors as add-on therapy to metformin for people with type 2 diabetes: a review of placebo-controlled trials in asian versus non-asian patients

SGLT2 inhibitors as add-on therapy to metformin for people with type 2 diabetes: a review of placebo-controlled trials in asian versus non-asian patients

Add to Collection
RCTs AJ Scheen - Diabetes, metabolic syndrome and obesity: targets …, 2020 - ncbi.nlm.nih.gov

Chapter : Section1
Journal Year : 2020
Cited by : 21.0

… the first pharmacological choice for treating hyperglycemia in type 2 diabetes (T2DM) in most … in India, was noninferior to dapagliflozin when added to metformin in Indian patients with …..... Read More

Keywords : ["asian versus nonasian patient", "type diabetes", "placebocontrolle trial", "addon therapy", "review", "people", "metformin", "inhibitor"]
PubMed Link : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7417649/
Google Scholar Link : https://scholar.google.com/scholar?cites=2951467450692165693&as_sdt=2005&sciodt=0,5&hl=en&num=20